A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

NCT05098197 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Liver Cancers
Tumor Infiltrating Lymphocyte
Treatment Side Effects
Effects of Immunotherapy
Advanced Pancreatic Cancers

Interventions

BIOLOGICAL: Tumor Infiltrating Lymphocyte

Sponsor

Shanghai Juncell Therapeutics

Collaborators

Shanghai 10th People's Hospital